Intervention
paclitaxel albumin-stabilized nanoparticle formulation
ClinicalTrials.gov intervention label
Advertisement
Clinical trials
19 shownPertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast CancerNCT01730833 · 2013-07-17
COMPLETEDCarboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast CancerNCT01525966 · 2012-02-15
ACTIVE_NOT_RECRUITINGS0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast CancerNCT00856492 · 2010-04-01
COMPLETEDPaclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerNCT00662129 · 2008-11-01
COMPLETEDPaclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerNCT00729612 · 2008-08-14
COMPLETEDPaclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung CancerNCT00748163 · 2008-08-01
WITHDRAWNCarboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast CancerNCT00616967 · 2008-05-01
ACTIVE_NOT_RECRUITINGNab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast CancerNCT00733408 · 2008-04-23
COMPLETEDCarboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryNCT00553462 · 2008-03-01
COMPLETEDParicalcitol and Chemotherapy in Treating Women With Metastatic Breast CancerNCT00637897 · 2008-03-01
COMPLETEDPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast CancerNCT00609791 · 2008-02-11
ACTIVE_NOT_RECRUITINGCarboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant SettingNCT00618657 · 2008-02-01
COMPLETEDABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast CancerNCT00404404 · 2006-10-01
UNKNOWNPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsNCT00499291 · 2006-09-01
WITHDRAWNCapecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast CancerNCT00397761 · 2006-07-01
WITHDRAWNBevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerNCT00436709 · 2006-07-01
UNKNOWNAbraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast CancerNCT00331630 · 2006-05-04
COMPLETEDDoxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With SurgeryNCT00407888 · 2006-05-01
COMPLETEDABI-007 in Treating Patients With Chemotherapy-Naïve Stage IV Non-Small Cell Lung CancerNCT00077246 · 2003-09-01
COMPLETEDCommon conditions
Breast Cancer10Lung Cancer4Stage IIIA Breast Cancer4Stage IIIB Breast Cancer4Stage IIIC Breast Cancer4HER2-positive Breast Cancer3Recurrent Breast Cancer3Stage IV Breast Cancer3HER2-negative Breast Cancer2Stage IA Breast Cancer2Stage IB Breast Cancer2Stage II Breast Cancer2Stage IIA Breast Cancer2Stage IIB Breast Cancer2Triple-negative Breast Cancer2Breast Adenocarcinoma1Cancer1Estrogen Receptor Negative1Estrogen Receptor-negative Breast Cancer1Estrogen Receptor-positive Breast Cancer1HER2/Neu Negative1Inflammatory Breast Cancer1Inflammatory Breast Carcinoma1Progesterone Receptor Negative1Progesterone Receptor-negative Breast Cancer1
Leading sponsors
City of Hope Medical Center3Alliance for Clinical Trials in Oncology2Memorial Sloan Kettering Cancer Center2University of Washington2Eastern Cooperative Oncology Group1Greg Otterson1Masonic Cancer Center, University of Minnesota1Medstar Health Research Institute1Northwestern University1Premiere Oncology1Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1SWOG Cancer Research Network1University of California, Irvine1Wake Forest University Health Sciences1
Trial status mix
COMPLETED11
ACTIVE_NOT_RECRUITING3
WITHDRAWN3
UNKNOWN2
Phase mix
PHASE215
NA2
PHASE12
EARLY_PHASE11
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.